Sysmex Strategic Investments

Profile and portfolio

Parent SysmexHQ Kobe, Japan

Sysmex Strategic Investments is the corporate venture arm of Sysmex, a healthcare company. It is based in Kobe, Japan. Sectors it names: healthcare and digital health, biotech and life sciences, medical devices.

Every figure links to its source

Where it invests

Geography

Headquarters: Kobe, Japan
Offices: Kobe, Japan

Investment regionsS5

Asia

Key facts

Fact	Value	Status	Source
Parent company	Sysmex (TSE: 6869)	Single source	S1
Parent industry	Healthcare and life sciences	Single source	S1
Headquarters	Kobe, Japan	Single source	S1
Status	Active	Single source	S1
Capital source	Parent company only	Single source	S5

About Sysmex

Item	Detail	Source
Listed as	TSE: 6869	S1
Headquarters	Japan	S1

Recent rounds

Date	Company	Round	Amount	Source
2025-05-13	Gaudi Clinical	Not stated	Not stated	S5
2021-05-12	ThinkCyte	Not stated	Not stated	S4
2020-01-29	Astrego Diagnostics	Not stated	Not stated	S3
2017-12-25	Megakaryon	Not stated	Not stated	S2

Portfolio

The firm's portfolio page lists 5 companies.S5

Shared portfolio with other corporate VCs

3 companies on the Sysmex Strategic Investments portfolio page also appear on the portfolio page of at least one other firm in this directory. Matched by company website, or by name where no website is published.

Firm	Shared	Companies in common
Future Creation Capital	1	Gaudi Clinical
Shizuoka Capital	1	Gaudi Clinical
Daikin CVC Office	1	Provigate
KIRIN Health Innovation Fund	1	ThinkCyte

Companies backed by the most corporate VCs

Every company on the Sysmex Strategic Investments list

5 companies, as listed on the firm's own website: 4 active, 1 listed.S5 Read the firm's list.

Active 4

Astrego Diagnostics
Gaudi Clinical
Megakaryon
ThinkCyte

Listed 1

Provigate

Official pages

Read the firm's own pages for current information.

Website www.sysmex.co.jp/

Sources

S1Sysmex: company profile (head office Kobe)Firm
S2Sysmex: investment in Megakaryon (iPS cell-derived platelets)Firm
S3Sysmex: investment in Astrego Diagnostics (urine test development)Firm
S4ThinkCyte: co-development and capital alliance with SysmexPortfolio company
S5Sysmex: business and capital alliance with Gaudi ClinicalFirm
S6Sysmex: Sysmex invests in Megakaryon to realise iPS-derived platelet preparations (2017-12-25)Firm
S7Sysmex: Megakaryon becomes a subsidiary to accelerate regenerative cell medicine (2023-12-21)Firm
S8Provigate: secured JPY 2 billion, Sysmex a participant (2024)Portfolio company
S9Wikipedia: Sysmex (headquarters Kobe)Third-party report

Disclaimer and corrections

Not affiliated. This page is not affiliated with, endorsed by or sponsored by Sysmex Strategic Investments or any company named on it. Names and trademarks belong to their owners. Informational only. This is a public-source reference. It is not investment, legal or tax advice and not an offer or solicitation. Sources. Each figure names its source. Figures may have changed. Please read the firm's official pages, linked above. Corrections and takedown. To report an error or ask for a change or removal, use the correction form or email Richard@CorporateVentureCapital.com.

Spotted a mistake? Report a correction.

Report a correction